EUVIMEDEUVIMED entdecken
Crossref

PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation

Qing Zhou, Yilin Guo, Ziying Tian, Yanbing Qiu, Ying Liu, Qingluan Liu, Yijun Liu, Yuqin Yang, Lei Shi, Xiayu Li, Ge Gao, Songqing Fan und 5 weitere

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024

DOI: 10.1016/j.bbadis.2024.167352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Qing Zhou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Clinical Labora…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Nasopharyngeal Carcinoma, Inflammasomes, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC) is a malignant tumor that occurs in the nasopharynx. Palate, lung, and nasal epithelium clone (PLUNC) has been identified as an early secreted protein that is specifically expressed in the nasopharynx. The aim of this study was to determine the role and mechanism of PLUNC in NPC. We used mRNA sequencing (seq) combined with ribosome-nascent chain complex (RNC)-seq to determine the biological role of PLUNC. The expression of epithelial-to-mesenchymal transition (EMT)-related molecules was detected by western blotting. Then, cell migration and invasion were detected by wound healing and Transwell chamber assays. NPC cells were injected into the tail vein of nude mice to explore the biological role of PLUNC in vivo. The sequencing results showed that PLUNC inhibited the progression of NPC and its expression was correlated with that of NOD-like receptors. Experiments confirmed that PLUNC inhibited the invasion and metastasis of NPC cells by promoting the ubiquitination degradation of NLRP3. PLUNC overexpression in combination with the treatment by MCC950, an inhibitor of NLRP3 inflammasome activation, was most effective in inhibiting NPC invasion and metastasis. In vivo experiments also confirmed that the combination of PLUNC overexpression and MCC950 treatment effectively inhibited the lung metastasis of NPC cells. In summary, our research suggested that PLUNC inhibited the invasion and metastasis of NPC by inhibiting NLRP3 inflammasome activation, and targeting the PLUNC-NLRP3 inflammasome axis could provide a new strategy for the diagnosis and treatment of NPC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinNasopharyngeal CarcinomaInflammasomesEpithelial-Mesenchymal TransitionNeoplasm InvasivenessNasopharyngeal NeoplasmsMice, NudePhosphoproteinsHumansAnimalsMiceCell Line, TumorCell MovementSulfonesIndenesSulfonamidesMaleFuransGene Expression Regulation, NeoplasticUbiquitinationFemaleMice, Inbred BALB CNeoplasm MetastasisGlycoproteins

Stichwörter der Autor:innen

MetastasisNLRP3Nasopharyngeal carcinomaPLUNCUbiquitination

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanInflammasomesPhosphoproteinsBPIFA1 protein, humanSulfonesN-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamideIndenesSulfonamidesFurans

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Clinical Laboratory, First Affiliated Hospital of Guizhou University of Traditional C…
  • Department of Medical Laboratory Science, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Medical Laboratory Science, Xiangya Medical College, Central South University, Changs…
  • Clinical Laboratory, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Department of Clinical Laboratory, Zhengzhou Orthopaedics Hospital, Zhengzhou, Henan, China.
  • Changsha Hospital for Maternal and Child Health Care, Changsha, Hunan, China.
  • Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Disease Genome Research Center, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

Förderung

  • Hunan Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Q., Guo, Y., Tian, Z., Qiu, Y., Liu, Y., Liu, Q., Liu, Y., Yang, Y., Shi, L., Li, X., Gao, G., Fan, S., Zeng, Z., Xiong, W., Tan, M., Li, G., & Zhang, W. (2024). PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167352

Vancouver

Zhou Q, Guo Y, Tian Z, Qiu Y, Liu Y, Liu Q, et al. PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167352

BibTeX
@article{Zhou2024,
  author = {Zhou, Qing and Guo, Yilin and Tian, Ziying and Qiu, Yanbing and Liu, Ying and Liu, Qingluan and Liu, Yijun and Yang, Yuqin and Shi, Lei and Li, Xiayu and Gao, Ge and Fan, Songqing and Zeng, Zhaoyang and Xiong, Wei and Tan, Ming and Li, Guiyuan and Zhang, Wenling},
  title = {PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2024},
  doi = {10.1016/j.bbadis.2024.167352}
}
Kostenlos starten →